HNGE — Hinge Health, Inc. Stock Price, Chart & AI Report

Positive Feb 24, 2026 • 16:50 UTC Investing.com • Leo Miller

Hinge Health’s AI Moat Might Be Its Patient Movement Data

Hinge Health, a mid-cap healthcare stock focused on virtual musculoskeletal therapy, is gaining traction with insurers as a cost-reduction solution amid rising U.S. healthcare costs. The company reported 46% revenue growth and 23% EPS growth, exceeding estimates, with a study showing 56% lower spinal fusion surgery rates among its users. However, the stock faces headwinds from high stock-based compensation and projected revenue growth deceleration to 25% in 2026.

HNGE UNH virtual physical therapy musculoskeletal conditions healthcare cost reduction AI coaching insurance partnerships stock-based compensation

Sentiment note

Strong earnings beat with 46% revenue growth and 23% EPS growth, expanding partnerships with 45% of Fortune 500 companies and major healthcare plans, proprietary patient movement data creating competitive moat, and positive clinical outcomes (56% lower surgery rates). However, tempered by high SBC expenses and projected growth deceleration.

Positive Feb 20, 2026 • 12:17 UTC The Motley Fool • James Halley

The High‑Growth Healthcare Stock Early Investors Will Brag About for the Next Decade

Hinge Health, a digital musculoskeletal health company that went public in May 2025, is rapidly growing with 51% revenue growth to $587.9 million in 2025 and expanding its corporate client base by 25% year-over-year. The company is leveraging AI-powered physical therapy solutions to help employers reduce healthcare costs and avoid expensive surgeries. Despite posting a net loss in 2025, it achieved $32 million in net income in Q4 and generated $61.5 million in free cash flow, with shares up only 7% since IPO, suggesting potential upside.

HNGE NVDA CRWD digital health physical therapy artificial intelligence healthcare costs musculoskeletal health

Sentiment note

Strong 51% revenue growth, expanding client base (25% YoY), improving profitability trajectory with Q4 net income of $32M, 65% YoY FCF growth, high gross margins (84%), innovative AI features, and stock trading below intrinsic value with only 7% gains since IPO despite strong fundamentals.

Positive Feb 11, 2026 • 15:28 UTC The Motley Fool • Rich Smith

Why Hinge Health Stock Popped on Wednesday

Hinge Health (HNGE) stock surged 7.99% after beating Q4 earnings expectations with $0.49 EPS on $170.7M in sales versus analyst forecasts of $0.43 EPS on $156.8M. The healthcare platform reported 46% YoY sales growth, expanded gross margins by 200 basis points, and generated $61.5M in free cash flow (up 65% YoY). The company forecasts 25% annual sales growth to $737M in 2026 with 29% non-GAAP earnings growth, trading at only 14.4x FCF.

HNGE earnings beat healthcare platform musculoskeletal conditions free cash flow sales growth gross margins valuation

Sentiment note

Company beat earnings expectations on both top and bottom lines, demonstrated strong revenue growth (46% YoY in Q4, 51% for full year), expanded margins, generated substantial free cash flow ($179.6M annually), and provided optimistic forward guidance with 25% projected annual sales growth. Trading at an attractive valuation of 14.4x FCF with expected 30%+ growth makes it an appealing investment opportunity.

Positive Jan 5, 2026 • 20:45 UTC Investing.com • Leo Miller

Notable Newcomers: These 2025 IPOs Dominated the Year

In 2025, over 200 U.S. IPOs occurred, with less than a quarter beating the S&P 500's 18% return. Three standout performers were Karman (defense/aerospace, +230%), Circle Internet Group (stablecoin issuer, +150%), and Hinge Health (digital physical therapy, +45%), all significantly outperforming the broader market.

KRMN CRCL HNGE IPO 2025 stock performance defense contractor cryptocurrency

Sentiment note

Solid 45% return with impressive 53% revenue growth, 200% increase in free cash flow margin, and strong analyst targets suggesting 32-47% additional upside. Addresses significant healthcare cost pain point with proven efficacy (95% reduction in human care hours).

Positive Dec 4, 2025 • 00:28 UTC The Motley Fool • Jonathan Ponciano

Up 44% Since IPO: Why a Major Fund Just Made a $45 Million Bet on This Digital Health Stock

Connecticut-based fund Braidwell initiated a $44.7 million stake in Hinge Health during Q3, representing 1.8% of its assets under management. The digital health company has shown strong growth, with 53% year-over-year revenue increase and expanding enterprise client base.

HNGE digital health musculoskeletal care healthcare technology SaaS investment

Sentiment note

Strong financial performance with 53% revenue growth, record free cash flow, 25% increase in clients, and positive market reception since IPO

Positive May 23, 2025 • 07:32 UTC Benzinga • Namrata Sen

Hinge Health Skyrockets On Wall Street Debut, Signals Comeback For Health-Tech IPOs: '...Tilts Things...Towards Potentially More Listings,' Says Analyst

Hinge Health, a digital physical therapy firm, had a strong debut on the NYSE, raising $273 million in its IPO. The stock surged 23% on its opening day, signaling a potential comeback for health-tech IPOs amid a sluggish tech IPO market.

HNGE Hinge Health IPO digital health physical therapy

Sentiment note

Hinge Health had a successful IPO, with its stock price surging 23% on its opening day, indicating strong investor interest in the company's digital physical therapy solutions.